PRECLINICAL STUDY OF NEW NANOPARTICLES WITH ANTICANCER AND MRI FUNCTIONS

被引：0
|
作者：
Lee, J. W.
Lee, J. I.
Lee, D. H. [1 ]
Kim, Y. S. [1 ]
Hong, S. -S. [1 ]
Maeng, J. -H. [1 ]
Jung, K. -H. [1 ]
机构：
[1] Inha Univ, Sch Med, Inchon, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60880-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S342 / S343
页数：2
相关论文
共 50 条
  • [31] REVISIONS OF GENERAL-GUIDELINES FOR THE PRECLINICAL TOXICOLOGY OF NEW CYTOTOXIC ANTICANCER AGENTS IN EUROPE
    BURTLES, SS
    NEWELL, DR
    HENRAR, REC
    CONNERS, TA
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (03) : 408 - 410
  • [32] Applications for Preclinical PET/MRI
    Judenhofer, Martin S.
    Cherry, Simon R.
    SEMINARS IN NUCLEAR MEDICINE, 2013, 43 (01) : 19 - 29
  • [33] PRECLINICAL MRI IN RADIATION THERAPY
    Seierstad, T.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S9 - S9
  • [34] PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer
    Tse, Brian Wan-Chi
    Cowin, Gary J.
    Soekmadji, Carolina
    Jovanovic, Lidija
    Vasireddy, Raja S.
    Ling, Ming-Tat
    Khatri, Aparajita
    Liu, Tianqing
    Thierry, Benjamin
    Russell, Pamela J.
    NANOMEDICINE, 2015, 10 (03) : 375 - 386
  • [35] Preclinical Study of Biofunctional Polymer-Coated Upconversion Nanoparticles
    Guryev, Evgenii L.
    Shilyagina, Natalia Y.
    Kostyuk, Alexey B.
    Sencha, Ludmila M.
    Balalaeva, Irina V.
    Vodeneev, Vladimir A.
    Kutova, Olga M.
    Lyubeshkin, Alexander V.
    Yakubovskaya, Raisa I.
    Pankratov, Andrei A.
    Ingel, Faina I.
    Novik, Tamara S.
    Deyev, Sergey M.
    Ermilov, Sergey A.
    Zvyagin, Andrei V.
    TOXICOLOGICAL SCIENCES, 2019, 170 (01) : 123 - 132
  • [36] MR-compatibility study of a preclinical digital PET/MRI insert
    Jakob Wehner
    Björn Weissler
    Peter Dueppenbecker
    Pierre Gebhardt
    Benjamin Goldschmidt
    Christoph Lerche
    Andre Salomon
    David Schug
    Volkmar Schulz
    EJNMMI Physics, 1 (Suppl 1)
  • [37] Fucoidan as a Marine Anticancer Agent in Preclinical Development
    Kwak, Jong-Young
    MARINE DRUGS, 2014, 12 (02) : 851 - 870
  • [38] Anticancer potential of curcumin: Preclinical and clinical studies
    Aggarwal, BB
    Kumar, A
    Bharti, AC
    ANTICANCER RESEARCH, 2003, 23 (1A) : 363 - 398
  • [39] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge J.J.
    Ahn C.-H.
    Andrews P.A.
    Brower M.E.
    Giorgio D.W.
    Goheer M.A.
    Lee-Ham D.Y.
    McGuinn W.D.
    Schmidt W.
    Sun C.J.
    Tripathi S.C.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (3) : 173 - 185
  • [40] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge, JJ
    Ahn, CH
    Andrews, PA
    Brower, ME
    Giorgio, DW
    Goheer, MA
    Lee-Ham, DY
    McGuinn, WD
    Schmidt, W
    Sun, CJ
    Tripathi, SC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (03) : 173 - 185
12345